BKYIIndustrials · Security & Protection Services

BKYI Stock Forecast: BIO-key International, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$2.65

−3.60% on the day

The 1 Wall Street analysts covering BIO-key International, Inc. hold a median 12-month price target of $20 — +654.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 46 of 100 as at 12 Sept 2026 — in the lower half.

Market cap

$3.8M

Ticker Nerd rank

46 / 100

Median analyst target

$20

Analysts covering

Revenue$1.9M+13.1% y/y

Operating income−$529K

Net income−$577K

Free cash flow−$846K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−6.0%

−32.0%

YTD

−50.9%

−65.1%

From 52W high

−74.3%

From 52W low

0.0%

$10

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

BKYI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores BIO-key International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

46 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Revisions

Accruals

Quality

Volatility

Growth

Value

Issuance

Momentum

Size (97): Smaller than most of the companies we track.

Momentum (7): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BKYI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BKYI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Low $20Median $20High $20

The green dot is the last close — the median target sits +654.4% from it.

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
26 Mar 2021	Maxim Group	Upgrade	Buy	$6.00
25 Nov 2020	Maxim Group	Downgrade	Hold	—
4 Oct 2019	Maxim Group	Downgrade	Hold	—
16 Aug 2018	Maxim Group	Maintains	Buy	$5.50 → $5.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BKYI appears on the weeks it earns a place.

Performance

BKYI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, BIO-key International, Inc. returned −65.1% against +17.5% for the S&P 500, dividends included.

BKYI vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BKYI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

BIO-key International, Inc. (BKYI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.4×
Price / sales: 0.6×
Price / book: 0.7×
EV / EBITDA: −1.1×

Growth & margins

Revenue growth (YoY): 13.1%
Earnings growth (YoY): 13.1%
Gross margin: 87.2%
Operating margin: −27.6%
Net margin: −90.1%

Returns & dividend

Return on equity: −107.9%
Return on assets: −22.8%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

BIO-key International, Inc. (BKYI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

BIO-key International, Inc. has a market value of $3.8M and an enterprise value of $3.3M.
Revenue in the twelve months to 30 June 2026: $6.7M. The latest quarter grew 13.1% year on year.
Net income over the same four quarters: −$6.0M, a −90.1% net margin.
Diluted earnings per share, trailing twelve months: $−4.11.
Free cash flow in the twelve months to 30 June 2026: −$4.2M, after $6K of capital spending.
Shares outstanding: 1.1M.
Trailing P/E: −0.4×; forward P/E: 12.1× — the forward figure prices analyst consensus estimates, not reported earnings.
BIO-key International, Inc. employs 41 people — $163K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

BKYI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSecurity & Protection Services

Company	Market cap	TKN rank
BKYIBIO-key International, Inc.	$3.8M	46
IVDAIveda Solutions, Inc.	$3.6M	16
VRMEVerifyMe, Inc.	$8.1M	40
SUGPSU Group Holdings Ltd.	$1.5M	8
GFAIGuardforce AI Co., Ltd.	$11.3M	16
SNTSenstar Technologies Corp.	$38.5M	5
BAERBridger Aerospace Group Holdings, Inc.	$59.9M	13

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own BIO-key International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BKYI news & analysis

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept.

GlobeNewsWire · 1 Sept 2026neutral

BIO-key International announced that its CEO, Michael DePasquale, will be available for virtual meetings at the H.C. Wainwright Global Investment Conference. The announcement was made via GlobeNewswire on September 1, 2026.

Why it matters — A BKYI watcher would care because the CEO's participation at a major investment conference gives the company an opportunity to present its identity and access management business to investors and potential partners.

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript

Seeking Alpha · 14 Aug 2026neutral

BIO-key International held its Q2 2026 earnings call, and Seeking Alpha published a transcript of the event.

Why it matters — The earnings call transcript provides BKYI watchers with management's detailed discussion of the company's financial results and operational performance for the quarter.

BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

GlobeNewsWire · 13 Aug 2026positive

BIO-key International reported a 13% rise in second-quarter revenues and a 51% improvement in its bottom line, driven by strength with government, defense, and financial sector customers globally. The company also announced an upcoming earnings call at 10am ET.

Why it matters — A BKYI watcher would care because the company's revenue growth and significantly improved bottom line suggest strengthening demand from key institutional sectors like government, defense, and finance.

Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security

GlobeNewsWire · 10 Aug 2026positive

The Portuguese national security agency has selected BIO-key (BKYI) and Visualforma to strengthen identity security, utilizing BIO-key's advanced identity and access management (IAM) and biometric authentication solutions.

Why it matters — This selection represents an adoption of BIO-key's IAM and biometric technology by a national government security agency, expanding its presence in the public sector.

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

GlobeNewsWire · 7 Aug 2026neutral

BIO-key International announced it will host its Q2 2026 investor call and webcast on Friday, August 14th at 10 a.m. ET. The company is a global provider of Identity and Access Management and biometric authentication technologies.

Why it matters — Investors and followers of BIO-key can obtain updates on the company's second-quarter performance directly from management during the scheduled call and webcast.

FAQ

Frequently asked questions about BKYI stock

What is the BKYI stock price forecast for 2026-2027?

The 1 Wall Street analysts covering BIO-key International, Inc. have a median 12-month price target of $20, with estimates ranging from $20 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BKYI stock a buy right now?

Of the 1 analysts covering BIO-key International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BIO-key International, Inc. 46 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BKYI?

As at 12 Sept 2026, BIO-key International, Inc. ranks 46 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).

Will BKYI stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +654.4% from the last close, and Ticker Nerd's factor model ranks BIO-key International, Inc. 46 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BKYI stock forecast for 2030?

No analyst covering BIO-key International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BKYI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $20 to $20 over the next 12 months.

How has BKYI stock performed over the past year?

BIO-key International, Inc. returned -65.1% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does BIO-key International, Inc. do?

BIO-key International, Inc. is a biometrics and identity access management company that develops fingerprint authentication and secure access software for organizations.

What is the latest news on BKYI?

The most recent item we track (GlobeNewsWire, 1 Sept 2026): "Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept.". BIO-key International announced that its CEO, Michael DePasquale, will be available for virtual meetings at the H.C. Wainwright Global Investment Conference. The announcement was made via GlobeNewswire on September 1, 2026.

Company

About BIO-key International, Inc.

BIO-key International, Inc. is a biometrics and identity access management company that develops fingerprint authentication and secure access software for organizations. BIO-key International, Inc. offers cloud-based and on-premise identity platforms, including PortalGuard and PortalGuard IDaaS, to support multi-factor authentication, single sign-on, passwordless login, privilege access control, and user provisioning. Its product portfolio also includes biometric identity verification tools, civil and large-scale identification systems, mobile authentication applications, and fingerprint readers for enterprise use. The company serves commercial, government, and education customers across industries that require secure workforce, student, citizen, and customer access management. Headquartered in Holmdel, New Jersey, and founded in 1993, BIO-key International, Inc. focuses on combining biometric hardware and software to simplify digital identity security and reduce reliance on traditional credentials.

CEO Mr. Michael W. DePasquale · 41 employees · United States · https://www.bio-key.com